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WU Polyomavirus in Respiratory
Epithelial Cells from Lung Transplant Patient
with Job Syndrome
Erica A. Siebrasse, Diana V. Pastrana,
Nang L. Nguyen, Annie Wang, Mark J. Roth,
Steven M. Holland, Alexandra F. Freeman,
John McDyer, Christopher B. Buck,
and David Wang
We detected WU polyomavirus (WUPyV) in a bronchoalveolar lavage sample from lungs transplanted into a recipient with Job syndrome by using immunoassays specific for
the WUPyV viral protein 1. Co-staining for an epithelial cell
marker identified most WUPyV viral protein 1–positive cells
as respiratory epithelial cells.

W

U polyomavirus (WUPyV) was discovered in a
child with pneumonia in 2007 (1). Subsequent
studies showed that WUPyV infection is common (2–4),
and viral DNA can be detected in a variety of specimen
types, including respiratory tract secretions (5). However, the virus has yet to be associated with any disease,
and the specific cell type(s) infected by WUPyV has not
been identified. Other human polyomaviruses are known
pathogens, which typically cause disease in the context of
immunosuppression (6–8).
Job syndrome is an immune disorder characterized
by eczematoid dermatitis, recurrent skin and pulmonary
infections, increased levels of IgE, and impaired T and
B cell memory (9). This disorder is caused by dominantnegative mutations in the STAT3 gene (9). We report
WUPyV cell tropism in lungs transplanted into a recipient
with Job syndrome.
The Study
These studies were approved by institutional review boards
at the National Institutes of Health (NIH) and Washington
University. A 28-year-old woman with Job syndrome was
seen at the NIH Clinical Center 6 months after bilateral lung
transplantation. She had a bronchoscopic evaluation to follow
up on endobronchial aspergillosis. Pathologic examination
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of a bronchoalveolar lavage (BAL) sample showed scattered
cells, primarily columnar bronchial cells, with cytomorphologic changes reminiscent of BK polyomavirus (BKPyV)–
infected decoy cells. The cells stained positive with PAb416,
a monoclonal antibody against the SV40 large T antigen.
The patient had BKPyV viremia (8.1 × 105 copies/mL) and
viruria (6.9 × 109 copies/mL). JC polyomavirus was also detected in the urine but not in the blood. The BAL sample was
weakly positive for BKPyV by PCR (<250 copies/mL) and
negative for JC polyomavirus. Clinical or radiographic signs
and symptoms of infection were not apparent.
Nonenveloped virions were purified from the BAL sample by using ultracentrifugation with Optiprep (#D1556; Sigma-Aldrich, St. Louis, MO, USA) (10). DNA was extracted
from the virion preparation and subjected to random-primed
rolling circle amplification (RCA) and restriction enzyme
digestion, which yielded 2 strong bands. The bands were
cloned and identified as WUPyV by using Sanger sequencing. The complete genomic sequence of the isolate, designated J1 (GenBank accession no. KJ643309), was confirmed
by using miSeq analysis (Illumnina, San Diego, CA, USA)
of the RCA product. A second WUPyV variant with 2-nt
polymorphisms and a single base insertion was also detected
in the RCA product. No other known viruses (including BKPyV) were observed by deep sequencing.
We developed an immunohistochemical (IHC) assay
to detect the WUPyV viral protein 1 (WU-VP1) by using
an IgG2b designated NN-Ab06. Recombinant histidinetagged WU-VP1 protein was generated by expressing WUVP1 (GenBank accession no. ABQ09289) in Escherichia
coli from a Gateway pDEST17 plasmid (Life Technologies,
Carlsbad, CA, USA) and purifying the protein by using an
affinity Ni-NTA column (Pierce Biotechnology, Rockford,
IL, USA). After generation of hybridomas, we identified
clones producing antibody against WU-VP1 by ELISA and
immunoblot. Clones that cross-reacted with KI polyomavirus VP1 (KI-VP1) were identified by ELISA with glutathione S-transferase–tagged KI-VP1 (2) and eliminated.
To generate positive control cells for IHC assay optimization, we transfected 293T cells with plasmid pDEST26WU-VP1 (Life Technologies). A subset of cells was fixed
in 10% neutral-buffered formalin and embedded in paraffin.
IHC testing was performed by deparaffinizing slides in xylene and rehydrating them in a series of ethanol solutions.
After treating slides with 3% hydrogen peroxide, antigen
was retrieved in citrate buffer, pH 6.0 (10 mmol/L citric
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acid, 0.05% Tween 20) in a pressure cooker (PC6–25; Nesco, Two Rivers, WI, USA) for 3 min on the high setting.
Slides were blocked in 1.5% normal horse serum (#S200; Vector Laboratories, Burlingame, CA, USA) and incubated with NN-Ab06, then with biotinylated anti-mouse
IgG (BA-2000; Vector Laboratories). After development
by using the Vectastain Avidin–Biotin Complex Kit (#PK6100; Vector Laboratories) and (3,3′-diaminobenzidine)
(#SK-4100; Vector Laboratories), we counterstained tissues with hematoxylin.
Cells with prominent dark staining were seen (Figure
1, panel A). A serial section of the same cell block stained
with an isotype-matched antibody (#557351, mouse IgG2b:
BD Biosciences, San Jose, CA, USA) (Figure 1, panel B)
and mock transfected cells stained with NN-Ab06 (Figure
1, panel C) showed negative results. Western blotting was
performed as an independent means of evaluating specificity of NN-Ab06 (11). NN-Ab06 reacted with WU-VP1 protein lysate but not with KI-VP1 lysate, which is the most
closely related virus to WUPyV. KI-VP1 has 65% amino
acid identity with WU-VP1.

We applied the WU-VP1 IHC assay to formalin-fixed,
paraffin-embedded sections of the BAL sample. Prominent
dark staining of cells with enlarged nuclei and a ground
glass appearance characteristic of viral cytopathic changes
were observed (Figure 1, panel D). Staining was not seen
in serial sections stained with the isotype antibody (Figure
1, panel E) or with no antibodies.
Many WUPyV-positive cells were cuboidal to columnar and showed other morphologic features consistent
with respiratory epithelial cells. To determine their etiology, we developed a double immunofluorescence (dIF)
assay with a polyclonal antibody against WU-VP1 (2),
designated NN-Ab01, and a monoclonal antibody against
cytokeratins (#M3515; Dako, Carpinteria, CA, USA). Deparaffinization and antigen retrieval were accomplished as
noted above, and sections were blocked in Superblock T20
(#37516; Thermo Scientific, Waltham, MA, USA). To validate the assay, we performed immunofluorescence analysis
with NN-Ab01 on positive control 293T cells expressing
WU-VP1. The nucleus was counterstained with Hoechst
(#H21491; Life Technologies). Several WU-VP1-positive

Figure 1. WU polyomavirus antigen in bronchoalveolar lavage specimens from lungs transplanted into a recipient (28-year-old woman) with
Job syndrome. Immunohistochemical analysis of 293T cells transfected with pDEST26-WU–virus protein 1 and stained as follows. A) WU virus
protein 1 monoclonal antibody (NN-Ab06). B) Isotype control. C) Mock transfected 293T cells stained with NN-Ab06. D) Bronchoalveolar lavage
specimen stained with NN-Ab06 showing prominent dark staining of cells with enlarged nuclei and a ground glass appearance characteristic of
viral cytopathic changes (arrows). E) Isotype control. Original magnifications ×400 in panels A–C and ×600 in panels D and E.
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Figure 2. WU polyomavirus
antigen in respiratory epithelial
cells from lungs transplanted
into a recipient (28-year-old
woman) with Job syndrome.
Immunofluorescence of 293T
cells transfected with pDEST26WU–virus protein 1 and stained
with A) WU virus protein 1
polyclonal antibody (NN-Ab01)
or B) preimmune serum. C)
Double immunofluorescence
with NN-Ab01 (red) and a
monoclonal antibody against
cytokeratin (green) showing
a double-positive cell from
the bronchoalveolar lavage
specimen. D) Bronchoalveolar
lavage specimen with multiple
WU virus protein 1/cytokeratin
double-positive cells. Original
magnifications ×100 in panels
A and B, ×600 in panel C, and
×400 in panel D.

cells were observed (Figure 2, panel A); a serial section
stained with preimmune serum at the same dilution showed
a negative result (Figure 2, panel B).
For dIF, BAL sections were incubated first with the
primary antibodies and then with fluorescently labeled secondary antibodies (#A10042 anti-rabbit-568 and #A10042
anti-mouse-488; Life Technologies). We observed cells
positive for WU-VP1 and cytokeratin (Figure 2, panels C,
D), which identified these cells as epithelial cells. Of the
136 WU-VP1-positive cells, 77 (57%) were also cytokeratin positive. A serial section of the BAL sample stained
with an isotype-matched antibody to the cytokeratin antibody (#555746 mouse IgG1; BD Biosciences) and preimmune rabbit serum was negative.
We hypothesized that the remaining 43% of WUVP1-positive, cytokeratin-negative cells might be macrophages. However, a dIF assay using NN-Ab01 and an
antibody against CD68 (#M0814; Dako), a macrophage
marker, showed WU-VP1 and CD68 single-positive cells
but no double-positive cells. In addition, a stain with
NN-Ab01 and an antibody against CD45 (#M351529–2;

Dako), a marker for hematopoietic cells, also showed
negative results.
Conclusions
Before this study, to our knowledge, no specific cell type
had been identified as susceptible to WUPyV infection. We
found that WUPyV antigen was detected in human respiratory epithelial cells. The presence of nuclease-resistant viral DNA from the Optiprep gradient and detection of WUVP1, which is believed to be expressed concomitantly with
DNA replication (12), suggests that the cells were infected
by WUPyV and that the WUPyV life cycle reached at least
the stage of late gene expression. The clinical role of infection by WUPyV is uncertain, given that the patient was
not experiencing any recognizable symptoms. Although
we attempted to identify a second population of WU-VP1positive, cytokeratin-negative cells, the etiologic features
of these cells remains uncertain.
Our patient had Job syndrome, a primary immunodeficiency not previously associated with polyomavirus susceptibility. It is possible that immunosuppressant medications,
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which include prednisone and tacrolimus, altered susceptibility to virus infection. Other human polyomaviruses are
believed to exclusively cause disease in immunocompromised hosts. This case suggests that immunosuppression
might also play a role in WUPyV infection and expands our
understanding of WUPyV biology.
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